Update on bazedoxifene: A novel selective estrogen receptor modulator
Diane M BiskobingDepartment of Medicine, Virginia Commonwealth University, Richmond, VA, USAAbstract: In the elderly population, osteoporosis is a significant clinical problem leading to disability and even death. Many patients remain untreated, despite effective therapies, because of patients&r...
Saved in:
Main Author: | Diane M Biskobing |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2007
|
Subjects: | |
Online Access: | https://doaj.org/article/7fc97ed35b6f49ffa5f831ab28d3fb65 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
by: Silvia Migliaccio, et al.
Published: (2007) -
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
by: Kawate H, et al.
Published: (2011) -
Selective estrogen receptor modulators: tissue specificity and clinical utility
by: Martinkovich S, et al.
Published: (2014) -
Effect of estrogens on skin aging and the potential role of SERMs
by: Susan Stevenson, et al.
Published: (2007) -
Rivastigmine in the treatment of Alzheimer's disease: an update
by: Maria Luisa Onor, et al.
Published: (2007)